ESMO Clinical Practice Guidelines: Hereditary Syndromes

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

Latest enhanced and revised set of guidelines

ESMO has Clinical Practice Guidelines on the following Hereditary Syndromes: Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes. They include information on incidence, diagnosis, staging and risk assessment, treatment and response evaluation and follow-up.